Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
BSF Enterprise PLC ( (GB:BSFA) ) has provided an announcement.
BSF Enterprise PLC’s subsidiary, 3D Bio-Tissues Ltd, is advancing the commercialization of lab-grown leather through a £50,000 Northern Accelerator Growth Support Grant. The company is transitioning its technology from lab-scale to pilot plant, collaborating with third parties to explore market opportunities in sectors like fashion, jewelry, and automotive. This move aims to establish Lab-grown Leather Ltd as a standalone entity, attracting investment without diluting current shareholders, and positioning BSF as a leader in sustainable leather innovation.
More about BSF Enterprise PLC
BSF Enterprise PLC develops and commercializes cutting-edge tissue-engineered solutions, including lab-grown leather, cultivated meat, and corneal repair technologies. The company leverages its proprietary scaffold-free platform to deliver sustainable alternatives to traditional materials, aiming to meet global demand for environmentally responsible innovations.
YTD Price Performance: -5.46%
Average Trading Volume: 751,663
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £2.66M
See more data about BSFA stock on TipRanks’ Stock Analysis page.

